Instil Bio (TIL) News Today $12.53 -0.14 (-1.10%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 23, 2024 | markets.businessinsider.comPremier Health Reports 2024 Second Quarter ResultsMay 10, 2024 | investorplace.comTIL Stock Earnings: Instil Bio Misses EPS for Q1 2024May 10, 2024 | markets.businessinsider.comInstil Bio, Inc. Q1 Loss DecreasesMay 10, 2024 | finance.yahoo.comInstil Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 10, 2024 | globenewswire.comInstil Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 1, 2024 | finance.yahoo.comBiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay HealthyApril 21, 2024 | msn.comThis actor once saw father saved murder accused, qualified for Olympics, then became Bollywood's top villain, died at...April 17, 2024 | msn.comInstil Bio (TIL) Price Target Decreased by 23.15% to 28.22April 12, 2024 | msn.comJefferies cuts Instil Bio to hold, cites drug discontinuationMarch 22, 2024 | seekingalpha.comInstil Bio Non-GAAP EPS of -$1.26 beats by $2.14March 21, 2024 | globenewswire.comInstil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 12, 2024 | ft.comA Very Private School — Charles Spencer’s privileged but painful educationMarch 11, 2024 | theguardian.comJon Cruddas: ‘Labour has to rediscover its moral purpose’February 24, 2024 | benzinga.comInstil Bio Stock (NASDAQ:TIL) Dividends: History, Yield and DatesFebruary 21, 2024 | sg.yahoo.comAlexei Navalny death latest: Putin brings new criminal case against critic’s brother as mother pleads for bodyFebruary 19, 2024 | msn.comHow RSS textbooks are reshaping Indian history and science under ModiFebruary 16, 2024 | thestreet.comInstil Bio Inc.February 5, 2024 | msn.comBoeing in ‘last chance saloon’, Emirates boss saysJanuary 17, 2024 | msn.comInstil Bio hits four-month high on rising volumesJanuary 16, 2024 | finance.yahoo.comInstil Bio Announces Strategic UpdateDecember 16, 2023 | msn.comInstil Bio (TIL) Price Target Increased by 1650.00% to 71.40December 13, 2023 | investorplace.comTIL Stock Earnings: Instil Bio Misses EPS for Q3 2023December 13, 2023 | investorplace.comTIL Stock Earnings: Instil Bio Misses EPS for Q1 2023December 8, 2023 | marketbeat.comTrading was temporarily halted for "TIL" at 07:12 PM with a stated reason of "News pending."December 5, 2023 | marketwatch.comInstil Bio Shares Fall 7% After Reverse Split NewsDecember 5, 2023 | finance.yahoo.comInstil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNovember 14, 2023 | msn.comInstil Bio Non-GAAP EPS of -$0.16 misses by $0.01November 13, 2023 | finance.yahoo.comInstil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comInstil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 6, 2023 | finance.yahoo.comInstil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNovember 4, 2023 | morningstar.comInstil Bio Inc TILSeptember 24, 2023 | money.usnews.comInstil Bio IncSeptember 7, 2023 | markets.businessinsider.comTruist Financial Remains a Hold on Instil Bio (TIL)August 31, 2023 | finance.yahoo.comAfter Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)August 17, 2023 | msn.comHC Wainwright & Co. Reiterates Instil Bio (TIL) Buy RecommendationAugust 14, 2023 | finance.yahoo.comInstil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 14, 2023 | finance.yahoo.comInstil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 2, 2023 | finance.yahoo.comCPMG Inc Acquires Significant Stake in Reata Pharmaceuticals IncAugust 2, 2023 | finance.yahoo.comNeurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business OfficerJuly 15, 2023 | fool.comInstil Bio (NASDAQ: TIL)July 6, 2023 | msn.comInstil Bio (TIL) Price Target Decreased by 20.00% to 4.08June 29, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Instil Bio (TIL) with Buy RecommendationJune 29, 2023 | benzinga.comHC Wainwright & Co. Initiates Coverage On Instil Bio with Buy Rating, Announces Price Target of $2June 29, 2023 | markets.businessinsider.comInstil Bio (TIL) Gets a Buy from H.C. WainwrightJune 26, 2023 | finance.yahoo.comInstil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceMay 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Instil Bio (TIL) and Regulus (RGLS)May 11, 2023 | marketwatch.com10-Q: INSTIL BIO, INC.May 11, 2023 | finance.yahoo.comInstil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 11, 2023 | finance.yahoo.comInstil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateApril 6, 2023 | benzinga.comInstil Bio Stock (NASDAQ:TIL), Short Interest Report Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. TIL Media Mentions By Week TIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TIL News Sentiment▼0.530.62▲Average Medical News Sentiment TIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TIL Articles This Week▼20▲TIL Articles Average Week Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENTA News Today RNAC News Today ADAP News Today AKBA News Today MRSN News Today ATAI News Today ZVRA News Today EPIX News Today CDXC News Today VTYX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TIL) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.